1-3 of 3
Niels Obel
Close
Sort by
Journal Articles

Low Serum Galectin-1 Levels Predict Future Lymphoma Development in HIV-Positive Patients

Maja Ludvigsen, MSc PhD, Maja Ølholm Vase, MD PhD, Rikke Hjortebjerg, MSc, Irma Petruskevicius, MD, Court Pedersen, Gitte Pedersen, Betina Sørensen, Mette Bjerre, Niels Obel, Bent Honoré, Carsten Schade Larsen, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2945.
https://doi.org/10.1182/blood.V128.22.2945.2945
Published: 2016
Journal Articles

High Intratumoral Expression of Galectin-1 Correlates with Superior Outcome in HIV-Associated DLBCL

Maja Ludvigsen, MSc PhD, Maja Ølholm Vase, MDPhD, Knud Bendix, Stephen Hamilton-Dutoit, Gabriel A Rabinovich, PhD, Michael Boe Moeller, Court Pedersen, Gitte Pedersen, Niels Obel, Carsten Schade Larsen, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4142.
https://doi.org/10.1182/blood.V128.22.4142.4142
Published: 2016
Journal Articles

HIV-1–related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4 + T-cell lymphocytes

Clinical Trials & Observations
Julia Bohlius, Kurt Schmidlin, François Boué, Gerd Fätkenheuer, Margaret May, Ana Maria Caro-Murillo, Amanda Mocroft, Fabrice Bonnet, Gary Clifford, Vassilios Paparizos, Jose M. Miro, Niels Obel, Maria Prins, Geneviève Chêne, Matthias Egger, Collaboration of Observational HIV Epidemiological Research Europe
Journal: Blood
Blood (2011) 117 (23): 6100–6108.
https://doi.org/10.1182/blood-2010-08-301531
Published: 2011
Includes: Supplemental data